Skip to main content
SpringerLink
Log in

Substance Use Disorders

  • Reference work entry
  • First Online:
Family Medicine

  • 153 Accesses

Abstract

A substance is any legal or illegal psychoactive material used by an individual with the potential for producing negative social and health concerns. Substances may be medically prescribed (i.e., hydrocodone) or recreational (i.e., marijuana). Substance use, misuse, and use disorder are part of a spectrum as discussed below. Substance misuse can reasonably be considered a lifestyle problem that may lead to harm. Effective preventive measures exist that may significantly reduce this harm and associated cost. Prolonged, repeated use of any addictive substances at high doses or frequency (quantity/frequency thresholds vary across substances) may lead to Substance Use Disorder (SUD). Disorders can range from mild and temporary to severe and chronic [1].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 899.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 999.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Katz M. Distinguishing between substance use and substance use disorder. JAMA Inter Med. 2015;175(12):1999.

    Article  Google Scholar 

  2. Bradbury A. Mental health and substance use disorders [Internet]. SAMHSA.gov. 2019. Available from: https://www.samhsa.gov/find-help/disorders

  3. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association, 2013.

    Google Scholar 

  4. Nathan P, Conrad M, Skinstad A. History of the concept of addiction. Annu Rev Clin Psychol. 2016;12(1):29–51.

    Article  Google Scholar 

  5. Pace C, Uebelacker L. Addressing unhealthy substance use in primary care. Med Clin North Am. 2018;102(4):567–86.

    Article  Google Scholar 

  6. Jack H, Oller D, Kelly J, Magidson J, Wakeman S. Addressing substance use disorder in primary care: the role, integration, and impact of recovery coaches. Subst Abus. 2017;39(3):307–14.

    Article  Google Scholar 

  7. Addiction medicine. New York: National Center on Addiction and Substance Abuse at Columbia University; 2012.

    Google Scholar 

  8. Key substance use and mental health indicators in the United States: results from the 2018 national survey on drug use and health. SAMHSA 2019. Available from: https://www.samhsa.gov/data/sites/default/files/cbhsq-reports/NSDUHNationalFindingsReport2018/NSDUHNationalFindingsReport2018.pdf.

  9. Monitoring the future 2019 survey results: overall findings. Drugabuse.gov. 2020. Available from: https://www.drugabuse.gov/related-topics/trends-statistics/infographics/monitoring-future-2019-survey-results-overall-findings

  10. Principles of drug addiction treatment: a research-based guide, 3rd edn. National Institute of Health; 2018.

    Google Scholar 

  11. Socías M, Volkow N, Wood E. Adopting the ‘cascade of care’ framework: an opportunity to close the implementation gap in addiction care? Addiction. 2016;111(12):2079–81.

    Article  Google Scholar 

  12. National Institute on Drug Abuse. Cascade of care model recommended for opioid crisis NIDA. 2019. Available from: https://www.drugabuse.gov/news-events/news-releases/2019/01/cascade-care-model-recommended-opioid-crisis

  13. Hasin D, O’Brien C, Auriacombe M, Borges G, Bucholz K, Budney A, et al. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013;170(8):834–51.

    Article  Google Scholar 

  14. Dziegielewski SF. DSM-5 in action. Hoboken: Wiley; 2015.

    Google Scholar 

  15. Saitz R, Larson MJ, LaBelle C, Richardson J, Samet JH. The case for chronic disease management for addiction. J Addict Med. 2008 Jun;2(2):55–65.

    Article  Google Scholar 

  16. Botticelli MP, Koh HK. Changing the language of addiction. JAMA. 2016;316:1361–2. https://doi.org/10.1001/jama.2016.11874.

    Article  PubMed  Google Scholar 

  17. National Council for Behavioral Health. Implementing care for alcohol and other drug use in medical settings: an extension of SBIRT. 2018. Available from: https://integration.samhsa.gov/sbirt/Implementing_Care_for_Alcohol_and_Other_Drug_Use_In_Medical_Settings_-_An_Extension_of_SBIRT.pdf

  18. Polcin DL, Nayak MB, Blacksher S. Addressing trauma among women with serious addictive disorders: treatment models, program factors, and potential mediators. J Drug Addict Educ Erad. 2008;4(3–4):221–37. PMID: 24348202

    PubMed  PubMed Central  Google Scholar 

  19. Substance Abuse and Mental Health Services Administration (SAMHSA). Clinical drug testing in primary care. Technical assistance publication (TAP) 32. HHS publication no. (SMA) 12–4668. Rockville: Substance Abuse and Mental Health Services Administration; 2012.

    Google Scholar 

  20. Moeller KE, Kissack JC, Atayee RS, Lee KC. Clinical interpretation of urine drug tests: what clinicians need to know about urine drug screens. Mayo Clin Proc. 2017;92(5):774–96.

    Article  CAS  Google Scholar 

  21. Mathews R, Hall W, Carter A. Direct-to-consumer genetic testing for addiction susceptibility: a premature commercialisation of doubtful validity and value. Addiction. 2012;107(12):2069–74.

    Article  Google Scholar 

  22. Knight JR, Mears CJ. Testing for drugs of abuse in children and adolescents: addendum--testing in schools and at home. Pediatrics. 2007;119(3):627–30.

    Article  Google Scholar 

  23. Quello SB, Brady KT, Sonne SC. Mood disorders and substance use disorder: a complex comorbidity. Sci Pract Perspect. 2005;3(1):13–21. PMID: 18552741

    Article  Google Scholar 

  24. McHugh RK, Hearon BA, Otto MK. Cognitive-behavioral therapy for substance use disorders. Psychiatr Clin North Am. 2010;33(3):511–25.

    Article  Google Scholar 

  25. Miller WR, Yahne CE, Tonigan JS. Motivational interviewing in drug abuse services: a randomized trial. J Consult Clin Psychol. 2003;71(4):754–63.

    Article  Google Scholar 

  26. Dimeff LA, Linehan MM. Dialectical behavior therapy for substance abusers. Addict Sci Clin Pract. 2008;4(2):39–47.

    Article  Google Scholar 

  27. Ries RK, Galanter M, Tonigan JS. In: Galanter M, Kleber HD, Brady KT, editors. Twelve-step facilitation: an adaptation for psychiatric practitioners and patients Chapter 28. Washington, DC: American Psychiatric Publishing; 2015.

    Google Scholar 

  28. Petry NM, Alessi SM, Marx J, Austin M, Tardif M. Vouchers versus prizes: contingency management treatment of substance abusers in community settings. J Consult Clin Psychol. 2005;73(6):1005–14.

    Google Scholar 

  29. Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoactive Drugs. 2003;35(2):253–9.

    Article  Google Scholar 

  30. Kosten TR, O'Connor PG. Management of drug and alcohol withdrawal. N Engl J Med. 2003;348(18):1786–95.

    Article  CAS  Google Scholar 

  31. Eggleston W, Clark KH, Marraffa JM. Loperamide abuse associated with cardiac dysrhythmia and death. Ann Emerg Med. 2017;69(1):83–6.

    Article  Google Scholar 

  32. Saxon AJ, Akerman SC, Chih-Chih L, Sullivan MA, Silverman BL, Vocci FJ. Extended-release naltrexone (XR-NTX) for opioid use disorder in clinical practice: Vivitrol’s cost and treatment outcomes registry. Addiction. 2018;113:1477–87. https://doi.org/10.1111/add.14199.

    Article  PubMed  Google Scholar 

  33. Johnson RE, Strain EC, Amass L. Buprenorphine: how to use it right. Drug Alcohol Depend. 2003;70(2 Suppl):S59–77.

    Article  CAS  Google Scholar 

  34. Johnson RE, Jones HE, Fischer G. Use of buprenorphine in pregnancy: patient management and effects on the neonate. Drug Alcohol Depend. 2003;70(2 Suppl):S87–101.

    Article  CAS  Google Scholar 

  35. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic pain — United States, 2016. MMWR Recomm Rep. 2016;65(RR-1):1–49.

    Article  Google Scholar 

  36. Sullivan JT, Sykora K, Schneiderman J, Naranjo CA, Sellers EM. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addict. 1989;84(11):1353–7.

    Article  CAS  Google Scholar 

  37. Kawasaki SS, Jacapraro JS, Rastegar DA. Safety and effectiveness of a fixed-dose phenobarbital protocol for inpatient benzodiazepine detoxification. J Subst Abus Treat. 2012;43(3):331–4.

    Article  Google Scholar 

  38. Mee-Lee D, Shulman GD, Fishman MJ, Gastfriend DR, Miller MM, editors. The ASAM criteria: treatment criteria for addictive, substance-related, and co-occurring conditions. 3rd ed. Carson City: The Change Companies; 2013. Copyright 2013 by the American Society of Addiction Medicine

    Google Scholar 

  39. Substance abuse and mental health services administration. Recovery-oriented systems of care (ROSC) resource guide. 2010. Available from: https://www.samhsa.gov/sites/default/files/rosc_resource_guide_book.pdf.

  40. Seligman NS, Rosenthal E, Berghella V. UpToDate [Internet]. Alphen aan den Rijn (The Netherlands): Wolters Kluwer; 2020. Overview of management of opioid use disorder during pregnancy; [updated 2020 Feb 14; cited 2020 Apr 30]; [about 20 screens]. Available from: https://www.uptodate.com/contents/overview-of-management-of-opioid-use-disorder-during-pregnancy.

  41. Cochran BN, Peavy KM, Robohm JS. Do specialized services exist for LGBT individuals seeking treatment for substance misuse? A study of available treatment programs. Subst Use Misuse. 2007;42(1):161–76.

    Article  Google Scholar 

  42. Kuerbis A, Sacco P, Blazer DG, Moore AA. Substance abuse among older adults. Clin Geriatr Med. 2014;30(3):629–54.

    Article  Google Scholar 

  43. Saloner B, Le Cook B. Blacks and Hispanics are less likely than whites to complete addiction treatment, largely due to socioeconomic factors. Health Aff. 2013;32(1):135–45.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family and Community Medicine, Baylor College of Medicine, Houston, TX, USA

    Alicia Kowalchuk, Sandra J. Gonzalez, Maria C. Mejia & Roger J. Zoorob

Authors
  1. Alicia Kowalchuk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sandra J. Gonzalez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria C. Mejia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Roger J. Zoorob
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alicia Kowalchuk .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of Nebraska Medical Center, Omaha, NE, USA

    Paul M. Paulman

  2. Department of Family and Community Medicine, Eastern Virginia Medical School, Norfolk, VA, USA

    Robert B. Taylor

  3. Department of Family Medicine, University of Nebraska Medical Center, Omaha, NE, USA

    Audrey A. Paulman

  4. Department of Family Medicine, Creighton University School of Medicine, Omaha, NE, USA

    Laeth S. Nasir

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Kowalchuk, A., Gonzalez, S.J., Mejia, M.C., Zoorob, R.J. (2022). Substance Use Disorders. In: Paulman, P.M., Taylor, R.B., Paulman, A.A., Nasir, L.S. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-3-030-54441-6_174

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-54441-6_174

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-54440-9

  • Online ISBN: 978-3-030-54441-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation